Tag: Bharat Biotech
Browse our exclusive articles!
Will Covid-19 nasal vaccine prove effective against infection? AIIMS expert says THIS
As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster...
DCGI approves for Bharat Biotech to conduct intranasal booster dose trials
The DGCI has approved Covaxin manufacturer, Bharat Biotech's Phase-III clinical trials for the intranasal booster dose BBV154 (Nasal covid vaccine) on individuals who...
Covaxin, Covidshield granted regular market approval for use in adults
India's drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to...
Covisheild, Covaxin price likely to be capped at Rs 275 per dose after DCGI approval
The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator, is...
When will COVID-19 vaccination drive for children start in India? Here’s what we know so far
Amid rising Omicron fears across the globe, doctors and experts have observed the rise of the COVID-19 cases among children in certain countries,...
